Skip to main content

Table 5 Unadjusted and adjusted Cox regression for clinical outcomes according to liver cirrhosis evaluated by APRI

From: Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients

 

Non-cirrhosis

Cirrhosis

p value

Unadjusted risk

MACCE

1(reference)

3.65 (2.05–6.52)

< 0.001

All-cause death

1(reference)

5.08 (2.22–11.62)

< 0.001

Cardiac death

1(reference)

9.95 (4.24–23.34)

< 0.001

MI

1(reference)

3.41 (1.25–9.30)

0.017

Ischemic stroke

1(reference)

3.03 (1.11–8.23)

0.030

TVR

1(reference)

1.12 (0.46–2.70)

0.81

Major bleeding

1(reference)

1.18 (0.38–3.68)

0.782

Stent thrombosis

1(reference)

6.06 (2.43–15.07)

< 0.001

Adjusted risk

MACCE

1(reference)

3.65 (1.99–6.69)

< 0.001

All-cause death

1(reference)

4.05 (1.68–9.75)

0.002

Cardiac death

1(reference)

8.19 (3.11–21.53)

< 0.001

MI

1(reference)

4.45 (1.55–12.73)

0.005

Ischemic stroke

1(reference)

3.24 (1.15–9.17)

0.026

TVR

1(reference)

1.06 (0.43–2.60)

0.90

Major bleeding

1(reference)

1.40 (0.44–4.45)

0.57

Stent thrombosis

1(reference)

8.39 (3.14–22.47)

< 0.001

  1. MACCE, major adverse cardiac and cerebrovascular event; MI, myocardial infarction; TVR, target vessel reconstruction. Values are hazard ratio (95% confidence interval)